Novo Nordisk and Eli Lilly launch anti-obesity pills and prepare for Medicare coverage
Nordisk and Eli Lilly They took their battle against the GLP-1 pill to the biggest meeting on obesity this weekend…
Novo Nordisk A/S
Shares of weight-loss drug makers plunge 25% as safety data spooks investors
Shares in weight-loss drug maker Zealand Pharma plunged as much as 26% on Monday after new data on its experimental…
AI healthcare tech startup Signos expands partnership with Dexcom
Signs combines a wearable glucose monitor with an app powered by artificial intelligence. Source: Signs Health technology startup Signos announced…
Eli Lilly's weight-loss drug retatrutide passes obesity trial
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
White House Adds Generic Drugs to TrumpRx Direct-to-Consumer Site
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House in Washington,…
Novo Nordisk releases new Wegovy data on high doses
A Wegovy injection pen is shown in Waterbury, Vermont, on April 28, 2025. Shelby Knowles | Bloomberg | fake images…
Novo Nordisk CEO Mike Doustdar says Ozempic maker looking for deals
Nordisk is looking for deals more than ever, the Danish drugmaker's CEO said Wednesday in an interview with CNBC. “If…
Eli Lilly (LLY) earnings in the first quarter of 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that beat estimates and raised its full-year sales outlook by $2…
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
The growing LPG-1 market
When Branneisha Cooper began receiving the GLP-1 injection in Mounjaro in late 2022, she heard online that she could experience…